Abstract 12924: CCL18 Promotes Effector Functions of Pro-Inflammatory Macrophages by Inactivating GSK-3β
Tuantuan Zhao(Mayo Clinic in Arizona), Cornelia M. Weyand(Mayo Clinic), Gerald J. Berry(Stanford University), Robert L. Frye(Mayo Clinic in Arizona), Zhao‐Lan Hu(Central South University), Jörg J. Goronzy(Mayo Clinic), Kenneth E. Bernstein(Cedars-Sinai Medical Center)
Cited by 2
Related Papers
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
|The Journal of Experimental Medicine|2016|534
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533